I was excited to participate in Allison Johnson’s recent Biocentury article reflecting on the growing interest of industry in allostery and why...
Read more
Most conventional small molecule drugs engage directly with the engine of a protein’s function, aiming to often turning off an...
Read more
In the quest towards building high-performing teams, biopharma can lift a page from the tech playbook around agile organizations. This...
Read more